ReleaseWire Connect

This report provides all the information you require to better understand Monsanto and its partnering interests and activities since 2010.

Prostate cancer - Market Insights, Epidemiology and Market Forecast-2020" Reports provides an overview of the disease and global market trends of the %Indication"% for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Prostate cancer forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Prostate cancer till 2020.

The Global Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies

Bladder cancer - Market Insights, Epidemiology and Market Forecast-2020" Reports provides an overview of the disease and global market trends of the %Indication"% for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Bladder cancer forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Bladder cancer till 2020.

Global Hospital Care Partnering 2010-2016: Deal trends, players and financials provides comprehensive understanding and unprecedented access to the hospital care partnering deals and agreements entered into by the worlds leading healthcare companies.

Dry eye disease - Market Insights, Epidemiology and Market Forecast-2020" Reports provides an overview of the disease and global market trends of the %Indication"% for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Dry eye disease forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Dry eye disease till 2020.

Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook discusses all gene therapies under the broad criteria of genetic material introduced to the cell for a therapeutic purpose. It includes not only the insertion of a gene into the cell for expression, but also gene silencing with RNA interference (RNAi) and antisense RNA, aptamers (DNA or RNA polymers which bind to a protein target), and oncolytic viruses.

Provides understanding and access to the idiopathic pulmonary fibrosis partnering deals and agreements entered into by the worlds leading healthcare companies.

Diabetes, often referred to as diabetes mellitus, results in high blood glucose levels. Depending on the cause of development, it can be divided into three types:

Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016 report provides an overview of the Wet (Neovascular / Exudative) Macular Degeneration pipeline landscape. The report provides comprehensive information on the therapeutics under development for Wet (Neovascular / Exudative) Macular Degeneration, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration and features dormant and discontinued projects.